<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2021-6.3.6</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-2847</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИНФЕКЦИОННЫЕ БОЛЕЗНИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INFECTIOUS DISEASES</subject></subj-group></article-categories><title-group><article-title>Перспективы использования синтетических селенорганических соединений для коррекции метаболического и иммунного статуса при вакцинальных процессах, вызванных живыми аттенуированными вакцинами против особо опасных инфекций</article-title><trans-title-group xml:lang="en"><trans-title>Prospects for the use of synthetic organoselenium compounds for the correction of metabolic and immune status during vaccination with live attenuated vaccines against especially dangerous infections</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7357-2219</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юрьева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yurieva</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> кандидат биологических наук, старший научный сотрудник лаборатории патофизиологии </p><p>тел.: 8 (3952) 22-01-35, факс: 8 (3952) 22-01-40</p><p> 664047, Иркутская область, г. Иркутск, ул. Трилиссера, 78, Россия </p></bio><bio xml:lang="en"><p> Cand. Sc. (Biol.), Senior Research Officer of Pathophysiological Laboratory</p><p> Trilissera st, 78, 664047, Irkutsk region, Irkutsk, Russian Federation </p></bio><email xlink:type="simple">olga.yur1963@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8561-6207</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дубровина</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Dubrovina</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p> доктор биологических наук, заведующая лабораторией патофизиологии </p><p>тел.: 8 (3952) 22-01-35, факс: 8 (3952) 22-01-40</p><p>664047, Иркутская область, г. Иркутск, ул. Трилиссера, 78, Россия </p></bio><bio xml:lang="en"><p> Dr. Sc. (Biol.), Head of Pathophysiological Laboratory </p><p> Trilissera st, 78, 664047, Irkutsk region, Irkutsk, Russian Federation </p></bio><email xlink:type="simple">dubrovina-valya@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6381-4517</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пятидесятникова</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Pyatidesyatnikova</surname><given-names>A. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p> младший научный сотрудник</p><p>тел.: 8 (3952) 22-01-35, факс: 8 (3952) 22-01-40</p><p>664047, Иркутская область, г. Иркутск, ул. Трилиссера, 78, Россия </p></bio><bio xml:lang="en"><p> Junior Research Officer of Pathophysiological Laboratory  </p><p> Trilissera st, 78, 664047, Irkutsk region, Irkutsk, Russian Federation </p></bio><email xlink:type="simple">adm@chumin.irkutsk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФКУЗ Иркутский научно-исследовательский противочумный&#13;
институт Роспотребнадзора</institution></aff><aff xml:lang="en"><institution>Irkutsk Antiplague Research Institute of Siberia and Far East of Rospotrebnadzor</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>12</day><month>08</month><year>2021</year></pub-date><volume>6</volume><issue>3</issue><fpage>60</fpage><lpage>69</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Юрьева О.В., Дубровина В.И., Пятидесятникова А.Б., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Юрьева О.В., Дубровина В.И., Пятидесятникова А.Б.</copyright-holder><copyright-holder xml:lang="en">Yurieva O.V., Dubrovina V.I., Pyatidesyatnikova A.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/2847">https://www.actabiomedica.ru/jour/article/view/2847</self-uri><abstract><p> В настоящей обзорной статье проведен анализ сведений, посвященных роли селена в регуляции метаболического и иммунного статуса макроорганизма. Рассмотрены данные  об эндогенных функциональных селенсодержащих  молекулах, к которым относятся селеноцистеин,  селенометионин, а также селенопротеины. Представлены  данные о патологиях, связанных с дефицитом этого микроэлемента, его иммунотропных свойствах и  адъювантных эффектах. Показана роль селенопротеинов в  регуляции окислительно-восстановительных процессов.  Проанализированы данные об иммунотропной активности соединений, содержащих селен и перспективах их использования в качестве адъювантов. Последний раздел посвящен анализу литературных данных о биологических свойствах синтетических соединений селена, обладающих активностью, имитирующей каталитическую активность  селенопротеинов. Проведенный в настоящей работе анализ сведений о функциональной активности селенопротеинов свидетельствует об их ключевой роли в регуляции  метаболических и иммунных процессов, а также в  поддержании гомеостаза. Представленные в обзоре сведения о биологической активности и механизмах действия новых  синтетических малотоксичных органических соединений селена могут послужить основой для разработки неспецифических  средств метаболической и иммунной коррекции вакцинальных процессов, вызванных как живыми аттенуированными  вакцинами, так и искусственно созданными. </p></abstract><trans-abstract xml:lang="en"><p> This review article analyzes the data on the role of selenium in the regulation of the metabolic and immune status of a macroorganism. The data on endogenousfunctional selenium-containing molecules, which include selenocysteine, selenomethionine, and selenoproteins, are considered. The data on the pathologies associated with the deficiency of this microelement, its  immunotropic properties and adjuvant effects are presented. The role of selenoproteins in the regulation of redox processes has been shown. The data on the immunotropic activity of compounds containing selenium and the prospects for their use as adjuvants are analyzed. The last section is devoted to the analysis of literature data on the biological properties of synthetic selenium compounds with an activity that mimics the catalytic activity of selenoproteins. The analysis of the data on the functional activity of selenoproteins carried out in this work indicates their key role in the regulation of metabolic and immune processes, as well as in maintaining homeostasis. The information presented in this review on the biological activity and mechanisms of action of new synthetic low-toxic organic compounds of selenium can serve as a basis for the development of nonspecific means of metabolic and immune correction of vaccinal processes caused by both live attenuated vaccines and artificially created ones. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>синтетические селенорганические соединения</kwd><kwd>миметики селенопротеинов</kwd><kwd>коррекция метаболического и иммунного статуса</kwd></kwd-group><kwd-group xml:lang="en"><kwd>synthetic organoselenium compounds</kwd><kwd>selenoprotein mimetics</kwd><kwd>correction of metabolic and immune status</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Awate S, Babiuk LA, Mutwiri G. Mechanisms of action of adjuvants. Front Immunol. 2013; 4:114. doi: 10.3389/fimmu.2013.00114</mixed-citation><mixed-citation xml:lang="en">Awate S, Babiuk LA, Mutwiri G. Mechanisms of action of adjuvants. Front Immunol. 2013; 4:114. doi: 10.3389/fimmu.2013.00114</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Afanas’eva GA, Chesnokova NP. On pathogenetic significance of activation of lipid peroxidation in the mechanisms of disturbance of blood rheologic properties in experimental intoxication induced by fraction FII of vaccinal EV strain of Y. pestis. Vestn Ross Akad Med Nauk. 2009; (2):14–8.</mixed-citation><mixed-citation xml:lang="en">Afanas’eva GA, Chesnokova NP. On pathogenetic significance of activation of lipid peroxidation in the mechanisms of disturbance of blood rheologic properties in experimental intoxication induced by fraction FII of vaccinal EV strain of Y. pestis. Vestn Ross Akad Med Nauk. 2009; (2):14–8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Русецкая Н. Ю. Бородулин В. Б. Биологическая активность селенорганических соединений при интоксикации солями тяжелых металлов. Биомедицинская химия. 2015; 61 (4): 449–461. doi: 10.18097/PBMC20156104449</mixed-citation><mixed-citation xml:lang="en">Rusetskaya NY, Borodulin VB. Biological activity of organoselenium compounds under intoxication with salts of heavy metals. Biomeditsinskaya сhimiya. 2015; 61 (4): 449–461. doi: 10.18097/PBMC20156104449 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Юрьева О. В., Дубровина В. И., Потапов В. А., Мусалов М. В., Старовойтова Т. П., Иванова Т. А. и др. Влияние синтетического селенорганического препарата на степень патоморфологических изменений органов белых мышей, иммунизированных туляремийной и бруцеллезной вакцинами. Бюллетень экспериментальной биологии и медицины. 2019; 168 (7): 76–79</mixed-citation><mixed-citation xml:lang="en">Yurieva OV, Dubrovina VI, Potapov VA, Musalov MV, Starovoitova TP, Ivanova TA et al. The effect of a synthetic organoselenium preparation on the degree of pathomorphological changes in the organs of white mice immunized with tularemia and brucellosis vaccines. Bulletin of Experimental Biology and Medicine. 2019; 168 (7): 76–79. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Avery JC, Hoffmann PR. Selenium, Selenoproteins, and Immunity. Nutrients. 2018; 10 (9): 1203. doi: 10.3390/nu10091203</mixed-citation><mixed-citation xml:lang="en">Avery JC, Hoffmann PR. Selenium, Selenoproteins, and Immunity. Nutrients. 2018; 10 (9): 1203. doi: 10.3390/nu10091203</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hamid M, Abdulrahim Y, Dandan Liu, Gang Qian, Khan A, Kehe Huang. The Hepatoprotective Effect of Selenium-Enriched Yeast and Gum Arabic Combination on Carbon TetrachlorideInduced Chronic Liver Injury in Rats. J Food Sci. 2018; 83 (2): 525–534. doi: 10.1111/1750–3841.14030</mixed-citation><mixed-citation xml:lang="en">Hamid M, Abdulrahim Y, Dandan Liu, Gang Qian, Khan A, Kehe Huang. The Hepatoprotective Effect of Selenium-Enriched Yeast and Gum Arabic Combination on Carbon TetrachlorideInduced Chronic Liver Injury in Rats. J Food Sci. 2018; 83 (2): 525–534. doi: 10.1111/1750–3841.14030</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mahmoodpoor A, Hamishehkar H, Shadvar K, Ostadi Z, Sanaie S, Saghaleini SH, et al.. The Effect of Intravenous Selenium on Oxidative Stress in Critically Ill Patients with Acute Respiratory Distress Syndrome. Immunol Invest. 2019; 48 (2): 147–159. doi: 10.1080/08820139.2018.1496098</mixed-citation><mixed-citation xml:lang="en">Mahmoodpoor A, Hamishehkar H, Shadvar K, Ostadi Z, Sanaie S, Saghaleini SH, et al. The Effect of Intravenous Selenium on Oxidative Stress in Critically Ill Patients with Acute Respiratory Distress Syndrome. Immunol Invest. 2019; 48 (2): 147–159. doi: 10.1080/08820139.2018.1496098</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhexi Liu, Jianwei Huang, Yijuan Nie, Qazi I H, Yutao Cao, Linli Wang, et al. Selenium Treatment Enhanced Clearance of Salmonella in Chicken Macrophages (HD11). Antioxidants (Basel, Switzerland). 2019; 8 (11): 532. doi:10.3390/antiox8110532</mixed-citation><mixed-citation xml:lang="en">Zhexi Liu, Jianwei Huang, Yijuan Nie, Qazi I H, Yutao Cao, Linli Wang, et al. Selenium Treatment Enhanced Clearance of Salmonella in Chicken Macrophages (HD11). Antioxidants (Basel, Switzerland). 2019; 8 (11): 532. doi:10.3390/antiox8110532</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Janbakhsh A, Mansouri F, Vaziri S, Sayad B, Afsharian M, et al. The effect of selenium on immunogenicity of influenza vaccine in the elderly: A case-control double-blinded clinical trial. J Kermanshah Univ Med Sci. 2016; 20 (1): e69746. doi: 10.22110/jkums.v20i1.3122</mixed-citation><mixed-citation xml:lang="en">Janbakhsh A, Mansouri F, Vaziri S, Sayad B, Afsharian M, et al. The effect of selenium on immunogenicity of influenza vaccine in the elderly: A case-control double-blinded clinical trial. J Kermanshah Univ Med Sci. 2016; 20 (1): e69746. doi: 10.22110/jkums.v20i1.3122</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mahdavi M, Mavandadnejad F, Yazdi MH, Faghfuri E, Hashemi H, Homayouni-Oreh S, et al. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model. J Infect Public Health. 2017; 10 (1): 102–109. doi: 10.1016/j.jiph.2016.02.006</mixed-citation><mixed-citation xml:lang="en">Mahdavi M, Mavandadnejad F, Yazdi MH, Faghfuri E, Hashemi H, Homayouni-Oreh S, et al. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model. J Infect Public Health. 2017; 10 (1): 102–109. doi: 10.1016/j.jiph.2016.02.006</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Hawkes WC, Kelley DS, Taylor PC. The effects of dietary selenium on the immune system in healthy men. Biol Trace Elem Res. 2001; 81 (3): 189–213. doi: 10.1385/BTER: 81:3:189</mixed-citation><mixed-citation xml:lang="en">Hawkes WC, Kelley DS, Taylor PC. The effects of dietary selenium on the immune system in healthy men. Biol Trace Elem Res. 2001; 81 (3): 189–213. doi: 10.1385/BTER: 81:3:189</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Yazdi MH, Varastehmoradi B, Faghfuri E, Mavandadnejad F, Mahdavi M, Shahverdi AR. Adjuvant Effect of Biogenic Selenium Nanoparticles Improves the Immune Responses and Survival of Mice Receiving 4T1 Cell Antigens as Vaccine in Breast Cancer Murine Model. J Nanosci Nanotechnol. 2015; 5 (12): 10165–10172. doi: 10.1166/jnn.2015.11692</mixed-citation><mixed-citation xml:lang="en">Yazdi MH, Varastehmoradi B, Faghfuri E, Mavandadnejad F, Mahdavi M, Shahverdi AR. Adjuvant Effect of Biogenic Selenium Nanoparticles Improves the Immune Responses and Survival of Mice Receiving 4T1 Cell Antigens as Vaccine in Breast Cancer Murine Model. J Nanosci Nanotechnol. 2015; 5 (12): 10165–10172. doi: 10.1166/jnn.2015.11692</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Yong Wang, Xuemei Cui, Lijia Yuan, Maqbool B, Wei Xu, Shanshan He, et al. A Solution with Ginseng Saponins and Selenium as Vaccine Diluent to Increase Th1/Th2 Immune Responses in Mice. J Immunol Res. 2020; ID 2714257. doi: 10.1155/2020/2714257</mixed-citation><mixed-citation xml:lang="en">Yong Wang, Xuemei Cui, Lijia Yuan, Maqbool B, Wei Xu, Shanshan He, et al. A Solution with Ginseng Saponins and Selenium as Vaccine Diluent to Increase Th1/Th2 Immune Responses in Mice. J Immunol Res. 2020; ID 2714257. doi: 10.1155/2020/2714257</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ma X, Bi S, Wang Y, Chi X, Hu S. Combined adjuvant effect of ginseng stem-leaf saponins and selenium on immune responses to a live bivalent vaccine of Newcastle disease virus and infectious bronchitis virus in chickens. Poult Sci. 2019; 98 (9): 3548-3556. doi: 10.3382/ps/pez207</mixed-citation><mixed-citation xml:lang="en">Ma X, Bi S, Wang Y, Chi X, Hu S. Combined adjuvant effect of ginseng stem-leaf saponins and selenium on immune responses to a live bivalent vaccine of Newcastle disease virus and infectious bronchitis virus in chickens. Poult Sci. 2019; 98 (9): 3548–3556. doi: 10.3382/ps/pez207</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Gabalov KP, Rumina MV, Tarasenko TN, et al. The adjuvant effect of selenium nanoparticles, Triton X-114 detergent micelles, and lecithin liposomes for Escherichia coli antigens. Appl Biochem Microbiol. 2017; 53: 587–593 doi: 10.1134/S0003683817050040</mixed-citation><mixed-citation xml:lang="en">Gabalov KP, Rumina MV, Tarasenko TN, et al. The adjuvant effect of selenium nanoparticles, Triton X-114 detergent micelles, and lecithin liposomes for Escherichia coli antigens. App lBiochem Microbiol. 2017; 53: 587–593. doi: 10.1134/S0003683817050040</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Z, Xuejiao Gao, Yongguo Cao, Haichao Jiang, Tiancheng Wang, Xiaojing Song, et al. Selenium Deficiency Facilitates Inflammation Through the Regulation of TLR4 and TLR4-Related Signaling Pathways in the Mice Uterus.Inflammation. 2015; 38 (3): 1347–1356. doi: 10.1007/s10753-014-0106-9</mixed-citation><mixed-citation xml:lang="en">Zhang Z, Xuejiao Gao, Yongguo Cao, Haichao Jiang, Tiancheng Wang, Xiaojing Song, et al. Selenium Deficiency Facilitates Inflammation Through the Regulation of TLR4 and TLR4-Related Signaling Pathways in the Mice Uterus.Inflammation. 2015; 38 (3): 1347–1356. doi: 10.1007/s10753-014-0106-9</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hugo V, Serrаo B, Scortecci JF. Why Selenocysteine Is Unique? Front. Mol. Biosci. 2020; 7 (2): 1–3. DOI: 10.3389/fmolb.2020.00002.</mixed-citation><mixed-citation xml:lang="en">Hugo V, Serrаo B, Scortecci JF. Why Selenocysteine Is Unique? Front. Mol. Biosci. 2020; 7 (2): 1–3. doi: 10.3389/fmolb.2020.00002</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, et al. Characterization of mammalian selenoproteomes. Science. 2003; 300: 1439–1443. doi: 10.1126/science.1083516</mixed-citation><mixed-citation xml:lang="en">Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, et al. Characterization of mammalian selenoproteomes. Science. 2003; 300: 1439–1443</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Xin Gen Lei, Wen-Hsing Cheng, McClung JP. Metabolic regulation and function of glutathione peroxidase-1. Annu Rev Nutr. 2007;27: 41–61. doi: 10.1146/annurev.nutr.27.061406.093716</mixed-citation><mixed-citation xml:lang="en">Xin Gen Lei, Wen-Hsing Cheng, McClung JP. Metabolic regulation and function of glutathione peroxidase-1. Annu Rev Nutr. 2007; 27: 41–61. doi: 10.1146/annurev.nutr.27.061406.093716</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Разыграев А. В., Матросова М. О., Титович И. А. Роль глутатионпероксидаз в ткани эндометрия: факты, гипотезы, перспективы изучения. Журнал акушерства и женских болезней. 2017; 66 (2): 104–111. doi: 10.17816/JOWD662104-111</mixed-citation><mixed-citation xml:lang="en">Razygraev AV, Matrosova MO, Titovich IA. Significance of glutathione peroxidases in endometrium function: facts, hypotheses, and research perspectives. Journal of obstetrics and women’s diseases. 2017; 66 (2): 104–111. doi: 10.17816/JOWD662104–111. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Carlson BA, Yoo MH, Shrimali RK, Irons R, Gladyshev VN, Hatfield DL, et al. Role of selenium-containing proteins in T-cell and macrophage function. Proc Nutr Soc. 2010; 69 (3): 300–310. doi: 10.1017/S002966511000176X</mixed-citation><mixed-citation xml:lang="en">Carlson BA, Yoo MH, Shrimali RK, Irons R, Gladyshev VN, Hatfield DL, et al. Role of selenium-containing proteins in T-cell and macrophage function. Proc Nutr Soc. 2010; 69 (3): 300–310. doi: 10.1017/S002966511000176X</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Crosley LK, Méplan C, Nicol F, Rundlöf AK, Arnér ES, Hesketh JE, Arthur JR. Differential regulation of expression of cytosolic and mitochondrial thioredoxin reductase in rat liver and kidney. Arch Biochem Biophys. 2007; 459 (2): 178–88. doi: 10.1016/j.abb.2006.12.029</mixed-citation><mixed-citation xml:lang="en">Crosley LK, Méplan C, Nicol F, Rundlöf AK, Arnér ES, Hesketh JE, Arthur JR. Differential regulation of expression of cytosolic and mitochondrial thioredoxin reductase in rat liver and kidney. Arch Biochem Biophys. 2007; 459 (2): 178–88. doi: 10.1016/j.abb.2006.12.029. Epub 2007 Jan 22. PMID: 17291446</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Лямина С. В., Малышев И. Ю. Поляризация макрофагов в современной концепции формирования иммунного ответа. Фундаментальные исследования. 2014; 10 (5): 930–935</mixed-citation><mixed-citation xml:lang="en">Lyamina SV, Malyshev IYu. Polarization of Macrophages in the Modern Concept of Formation of the Immune Response. Basic research. 2014; 10: 930–935. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Артыкбаева Г. М. Роль дейодиназ 1-го и 2-го типа в метаболизме тиреоидных гормонов. Проблемы эндокринологии. 2016; 2: 46–52. doi.org/10.14341/probl201662246-52</mixed-citation><mixed-citation xml:lang="en">Artykbaeva G. M. The role of type 1 and type 2 deiodinases in thyroid hormone metabolism. Endocrinology problems. 2016; 2: 46–52. doi.org/10.14341/probl201662246–52 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lee BC, Péterfi Z, Hoffmann FW, Moore RE, Kaya A, Avanesov A, et al. MsrB1 and MICALs regulate actin assembly and macrophage function via reversible stereoselective methionine oxidation. Mol Cell. 2013; 51 (3): 397–404. doi: 10.1016/j.molcel.2013.06.019</mixed-citation><mixed-citation xml:lang="en">Lee BC, Péterfi Z, Hoffmann FW, Moore RE, Kaya A, Avanesov A, et al. MsrB1 and MICALs regulate actin assembly and macrophage function via reversible stereoselective methionine oxidation. Mol Cell. 2013; 51 (3): 397–404. doi: 10.1016/j.molcel.2013.06.019</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Xiaoxiang Zheng, Bingyu Ren, Heng Wang, Ruikun Huang, Jun Zhou, Hongmei Liu, et al. Hepatic proteomic analysis of selenoprotein F knockout mice by iTRAQ: An implication for the roles of selenoprotein F in metabolism and diseases. J Proteomics. 2020; 215:103653. doi: 10.1016/j.jprot.2020.103653</mixed-citation><mixed-citation xml:lang="en">Xiaoxiang Zheng, Bingyu Ren, Heng Wang, Ruikun Huang, Jun Zhou, Hongmei Liu, et al. Hepatic proteomic analysis of selenoprotein F knockout mice by iTRAQ: An implication for the roles of selenoprotein F in metabolism and diseases. J Proteomics. 2020; 215:103653. doi: 10.1016/j.jprot.2020.103653</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Yim SH, Everley RA, Schildberg FA, Lee SG, Orsi A, Barbati ZR, et al. Role of Selenof as a Gatekeeper of Secreted Disulfide-Rich Glycoproteins. Cell Rep. 201823 (5), 1387–1398. doi: 10.1016/j.celrep.2018.04.009</mixed-citation><mixed-citation xml:lang="en">Yim SH, Everley RA, Schildberg FA, Lee SG, Orsi A, Barbati ZR, et al. Role of Selenof as a Gatekeeper of Secreted Disulfide-Rich Glycoproteins. Cell Rep. 201823 (5), 1387–1398. doi: 10.1016/j.celrep.2018.04.009</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Bertz M, Kühn K, Koeberle SC, Müller MF, Hoelzer D, Thies K, et al. Selenoprotein H controls cell cycle progression and proliferation of human colorectal cancer cells. Free Radic Biol Med. 2018; 127: 98–107. doi: 10.1016/j.freeradbiomed. 2018.01.010</mixed-citation><mixed-citation xml:lang="en">Bertz M, Kühn K, Koeberle SC, Müller MF, Hoelzer D, Thies K, et al. Selenoprotein H controls cell cycle progression and proliferation of human colorectal cancer cells. Free RadicBiol Med. 2018; 127: 98–107. doi: 10.1016/j.freeradbiomed.2018.01.010</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Horibata Y, Elpeleg O, Eran A, Hirabayashi Y, Savitzki D, Tal G, et al. EPT1 (selenoprotein I) is critical for the neural development and maintenance of plasmalogen in humans. J Lipid Res. 2018; 59 (6): 1015–1026. doi: 10.1194/jlr.P081620</mixed-citation><mixed-citation xml:lang="en">Horibata Y, Elpeleg O, Eran A, Hirabayashi Y, Savitzki D, Tal G, et al. EPT1 (selenoprotein I) is critical for the neural development and maintenance of plasmalogen in humans. J Lipid Res. 2018; 59 (6): 1015–1026. doi: 10.1194/jlr.P081620</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Marciel MP, Hoffmann PR. Molecular Mechanisms by Which Selenoprotein K Regulates Immunity and Cancer. Biol Trace Elem Res. 2019; 192 (1): 60–68. doi: 10.1007/s12011-019-01774-8</mixed-citation><mixed-citation xml:lang="en">Marciel MP, Hoffmann PR. Molecular Mechanisms by Which Selenoprotein K Regulates Immunity and Cancer. Biol Trace Elem Res. 2019; 192 (1): 60–68. doi: 10.1007/s12011-019-01774-8</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Hao Jiang, Qian Qian Shi, Li Yuan Ge, Qian Feng Zhuang, Dong Xue, et al. Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway. Cancer Med. 2019; 8 (10): 4836–4844. doi: 10.1002/cam4.2403</mixed-citation><mixed-citation xml:lang="en">Hao Jiang, Qian Qian Shi, Li Yuan Ge, Qian Feng Zhuang, Dong Xue, et al. Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway. Cancer Med. 2019; 8 (10): 4836–4844. doi: 10.1002/cam4.2403</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Ziyaee F, Shorafa E, Dastsooz H, Habibzadeh P, Nemati H, Saeed A, Silawi M, Farazi Fard MA, Faghihi MA, Dastgheib SA. A novel mutation in SEPN1 causing rigid spine muscular dystrophy 1: a Case report. BMC Medical Genetics. 2019; 20 (1): 13. doi: 10.1186/s12881-018-0743-1. PMID: 30642275</mixed-citation><mixed-citation xml:lang="en">Ziyaee F, Shorafa E, Dastsooz H, Habibzadeh P, Nemati H, Saeed A, Silawi M, Farazi Fard MA, Faghihi MA, Dastgheib SA. A novel mutation in SEPN1 causing rigid spine muscular dystrophy 1: a Case report. BMC Medical Genetics. 2019; 20 (1):13. doi: 10.1186/s12881-018-0743-1. PMID: 30642275</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Han SJ, Lee BC, Yim SH, Gladyshev VN, Lee SR. Characterization of mammalian selenoprotein o: a redoxactive mitochondrial protein. PLoS One. 2014; 9 (4): e95518 doi: 10.1371/journal.pone.0095518</mixed-citation><mixed-citation xml:lang="en">Han SJ, Lee BC, Yim SH, Gladyshev VN, Lee SR. Characterization of mammalian selenoprotein o: a redoxactive mitochondrial protein. PLoS One. 2014; 9 (4): e95518. doi: 10.1371/journal.pone.0095518</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Shanshan Yu, Jianling Du. Selenoprotein S: a therapeutic target for diabetes and macroangiopathy?. Cardiovasc Diabetol. (2017). doi: 10.1186/s12933-017-0585-8</mixed-citation><mixed-citation xml:lang="en">Yu Ss, Du Jl. Selenoprotein S: a therapeutic target for diabetes and macroangiopathy?. Cardiovasc Diabetol (2017). doi: 10.1186/s12933-017-0585-8</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Pitts MW, Hoffmann PR. Endoplasmic reticulumresident selenoproteins as regulators of calcium signaling and homeostasis. Cell Calcium. 2018; 70: 76–86. doi: 10.1016/j.ceca.2017.05.001</mixed-citation><mixed-citation xml:lang="en">Pitts MW, Hoffmann PR. Endoplasmic reticulumresident selenoproteins as regulators of calcium signaling and homeostasis. Cell Calcium. 2018; 70: 76–86. doi: 10.1016/j.ceca.2017.05.001</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Barbosa NV, Nogueira CW, Nogara PA, de Bem AF, Aschner M, Rocha JBT. Organoselenium compounds as mimics of selenoproteins and thiol modifier agents. Metallomics. 2017; 9 (12): 1703–1734. doi: 10.1039/c7mt00083a</mixed-citation><mixed-citation xml:lang="en">Barbosa NV, Nogueira CW, Nogara PA, de Bem AF, Aschner M, Rocha JBT. Organoselenium compounds as mimics of selenoproteins and thiol modifier agents. Metallomics. 2017; 9 (12): 1703–1734. doi: 10.1039/c7mt00083a</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020; 582: 289–293. doi: 10.1038/s41586-020-2223-y</mixed-citation><mixed-citation xml:lang="en">Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020; 582: 289–293. doi: 10.1038/s41586-020-2223-y</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Zmudzinski M, Rut LW, Olech K, Granda J, Giurg M, Grabowska MB, et al. Ebselen derivatives are very potent dual inhibitors of SARS-CoV-2 proteases – PLpro and Mpro in in vitro studies. 2020. (preprint). doi: 10.1101/2020.08.30.273979</mixed-citation><mixed-citation xml:lang="en">Zmudzinski M, Rut LW, Olech K, Granda J, Giurg M, Grabowska MB, et al. Ebselen derivatives are very potent dual inhibitors of SARS-CoV-2 proteases – PLpro and Mpro in in vitro studies. 2020. (preprint). doi: 10.1101/2020.08.30.273979</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Полубояринов П. А., Елистратов Д. Г., Швец В. И. Метаболизм и механизм токсичности селенсодержащих препаратов, используемых для коррекции дефицита микроэлемента селена. Тонкие химические технологии. 2019; 14 (1): 5–24. doi: 10.32362/2410-6593-2019-14-1-5-24</mixed-citation><mixed-citation xml:lang="en">Poluboyarinov PA, Elistratov DG, Shvets VI. Metabolism and mechanism of toxicity of selenium-containing drugs used to correct the deficiency of the microelement selenium. Fine chemical technologies. 2019; 14 (1): 5–24. doi: 10.32362/2410-6593-2019-14-1-5-24 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Potapov VA, Musalov MV, Musalova MV, Amosova SV. Recent Advances in Organochalcogen Synthesis Based on Reactions of Chalcogen Halides with Alkynes and Alkenes. Current Organic Chemistry. 2016; 20: 136–145</mixed-citation><mixed-citation xml:lang="en">Potapov VA, Musalov MV, Musalova MV, Amosova SV. Recent Advances in Organochalcogen Synthesis Based on Reactions of Chalcogen Halides with Alkynes and Alkenes. Current Organic Chemistry. 2016; 20: 136–145</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Мусалов М. В., Потапов В. А., Мусалова М. В., Амосова С. В. Региоселективный синтез бис [(2,3-ди- гидро-1-бензофуран-2-ил) метил] селенида. Журн. органической химии. 2014; 50 (11): 1712–1713</mixed-citation><mixed-citation xml:lang="en">Musalov MV, Potapov VA, Musalova MV, Amosova SV. Regioselective synthesis of bis [ (2,3-di-hydro-1-benzofuran-2-yl) methyl] selenide. Journal. Organic chemistry. 2014; 50 (11): 1712–1713 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Юрьева О. В., Дубровина В. И. Роль сигнальных систем циклических нуклеотидов в регуляции иммуно- и патогенеза. Бюллетень ВСНЦ СО РАМН. 2012; 84 (2): 159–163</mixed-citation><mixed-citation xml:lang="en">Yurieva OV, Dubrovina VI. The role of signaling systems of cyclic nucleotides in the regulation of immuno- and pathogenesis. Bulletin of the All-Russian Scientific Center of the Russian Academy of Medical Sciences. 2012; 84 (2): 159–163. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Юрьева О. В., Дубровина В. И., Потапов В. А., Мусалов М. В., Старовойтова Т. П., Иванова Т. А. и др. Результаты исследования иммунотропных свойств экспериментального синтетического селенорганического соединения. Бюллетень экспериментальной биологии и медицины. 2020; 169 (1): 45–48</mixed-citation><mixed-citation xml:lang="en">Yurieva OV, Dubrovina VI, Potapov VA, Musalov MV, Starovoitova TP, Ivanova TA, et al. Results of a study of the immunotropic properties of an experimental synthetic organoselenium compound. Bulletin of Experimental Biology and Medicine. 2020; 169 (1): 45–48. (In Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
